Biofrontera Inc. (BFRI) Misses Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Biofrontera (BFRI) PT Lowered to $16 at Roth/MKM
August 15, 2024 1:44 PM EDTRoth/MKM analyst Jonathan Aschoff lowered the price target on Biofrontera (NASDAQ: BFRI) to $16.00 (from $25.00) while maintaining a Buy rating.
The analyst comments "BFRI ended 2Q24 with cash of $4.4M, enough to fund operations into early 2025. 2Q24 sales were $7.8M and we still... More



